Financhill
Back

Revance Therapeutics Vs. Anebulo Pharmaceuticals Industry Stock Comparison

Sell
9

RVNC
Revance Therapeutics

Last Price:
3.73
Seasonality Move:
6.97%
Sell
38

ANEB
Anebulo Pharmaceuticals

Last Price:
1.59
Seasonality Move:
20.03%
Sell
9
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.73. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
38
Anebulo Pharmaceuticals (ANEB) is a Sell

Is Anebulo Pharmaceuticals a Buy, Sell or Hold?

  • The current Anebulo Pharmaceuticals [ANEB] share price is $1.46. The Score for ANEB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ANEB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.

ANEB Stock Price Chart

What is Anebulo Pharmaceuticals's stock price today?

  • The Anebulo Pharmaceuticals share price today is $1.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANEB is experiencing slight selling pressure.

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.99 Sell
Chaikin Money Flow: -1111191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.97 - 5.77) Sell
Bollinger Bands (100): (3.78 - 6.28) Sell

ANEB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 36.57 Sell
Chaikin Money Flow: -1719 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.55 - 1.87) Sell
Bollinger Bands (100): (1.72 - 2.26) Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.98 Sell
20-day SMA: 4.79 Sell
50-day SMA: 5.16 Sell
200-day SMA: 4.6 Sell
8-day EMA: 3.99 Sell
20-day EMA: 4.48 Sell
50-day EMA: 4.92 Sell
200-day EMA: 6.01 Sell

ANEB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.52 Sell
20-day SMA: 1.67 Sell
50-day SMA: 1.87 Sell
200-day SMA: 2.29 Sell
8-day EMA: 1.53 Sell
20-day EMA: 1.64 Sell
50-day EMA: 1.8 Sell
200-day EMA: 2.16 Sell

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Anebulo Pharmaceuticals Earnings Growth & ANEB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.09 per share.

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Anebulo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):